LEEP, Inc. engages in producing and shipping structures for U.S. Government use. The company is headquartered in Twin Falls, Idaho. LeepCore is a galvanized steel skin, polyurethane foam core, load-bearing SIP that is used to construct walls, roofs, and floors. LeepCore structural panels are insulated framed or frameless construction panels that can construct freestanding walls, floors, and roofs of residential and commercial buildings. Its LeepCore applications include single-family homes, multi-family homes, education, commercial, military, and remote sites, and emergency and portable housing. LeepCore is used for both permanent and portable classroom, and academic construction. The firm has projects in Houston, Baker County, and South Carolina. The company also provides tiny homes, which includes applications such as temporary, modular, and government. Temporary includes portable office space for construction sites and Triage Center. Modular includes Cabins or off the grid living and Movable homes.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue
55
55
98
90
92
101
Revenue Growth (YoY)
-44%
-44%
9%
-2%
-9%
-34%
Cost of Revenue
0
0
30
33
21
24
Gross Profit
55
55
67
56
70
77
Selling, General & Admin
68
68
76
77
92
122
Research & Development
117
117
120
114
218
400
Operating Expenses
186
186
197
191
310
523
Other Non Operating Income (Expenses)
0
0
0
-6
0
-24
Pretax Income
-155
-155
-119
-276
-365
-523
Income Tax Expense
0
0
0
0
3
0
Net Income
-164
-164
-118
-276
-368
-523
Net Income Growth
39%
39%
-56.99%
-25%
-30%
18%
Shares Outstanding (Diluted)
20.33
16.87
13.71
12.66
12.47
12.21
Shares Change (YoY)
45%
23%
8%
2%
2%
3%
EPS (Diluted)
-8.06
-9.72
-8.67
-21.79
-29.51
-42.86
EPS Growth
-5%
12%
-60%
-26%
-31%
15%
Free Cash Flow
-209
-209
-177
-193
-309
-427
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
100%
100%
68.36%
62.22%
76.08%
76.23%
Operating Margin
-236.36%
-236.36%
-131.63%
-150%
-260.86%
-441.58%
Profit Margin
-298.18%
-298.18%
-120.4%
-306.66%
-400%
-517.82%
Free Cash Flow Margin
-380%
-380%
-180.61%
-214.44%
-335.86%
-422.77%
EBITDA
-129
-129
-125
-128
-227
-432
EBITDA Margin
-234.54%
-234.54%
-127.55%
-142.22%
-246.73%
-427.72%
D&A For EBITDA
1
1
4
7
13
14
EBIT
-130
-130
-129
-135
-240
-446
EBIT Margin
-236.36%
-236.36%
-131.63%
-150%
-260.86%
-441.58%
Effective Tax Rate
0%
0%
0%
0%
-0.82%
0%
Follow-Up Questions
What are Leep Inc's key financial statements?
According to the latest financial statement (Form-10K), Nektar Therapeutics has a total asset of $280, Net loss of $-164
What are the key financial ratios for LPPI?
Nektar Therapeutics's Current ratio is 1.47, has a Net margin is -298.18, sales per share of $3.26.
How is Leep Inc's revenue broken down by segment or geography?
Nektar Therapeutics largest revenue segment is Novel Drug Candidates, at a revenue of 90,122,000 in the most earnings release.For geography, Rest of World is the primary market for Nektar Therapeutics, at a revenue of 78,641,000.
Is Leep Inc profitable?
no, according to the latest financial statements, Nektar Therapeutics has a net loss of $-164
Does Leep Inc have any liabilities?
yes, Nektar Therapeutics has liability of 190
How many outstanding shares for Leep Inc?
Nektar Therapeutics has a total outstanding shares of 20.37